Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • Article

    In Proposed Regulations CMS Requests Information On Changes To Part D Negotiated Prices

    Today is the deadline for interested parties to submit comments to CMS regarding the proposed contract year 2019 Medicare Advantage and Part D regulations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
    Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Article

    CMS Finalizes Changes To Bona Fide Service Fee Requirements, Alongside Other Adjustments To Medicare Part B Drug Reimbursement Methodology

    On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule for the Calendar Year (CY) 2026 Physician Fee Schedule (PFS), detailing significant updates to Medicare Part B payment policies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    OIG Technical Assistance On Part B Inflation Rebates Implementation Barriers And CMS' Proposed Solutions In Recent Part B Inflation Rebate Initial Guidance

    On February 7, 2023, the U.S. Department of Health and Human Services Office of Inspector General (OIG) published a report entitled, "Technical Assistance Brief...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley Hoag LLP
    Foley Hoag LLP
  • Article

    CMS Issues Additional Guidance On The Organ Donation Process

    The Centers for Medicare & Medicaid Services' (CMS) 2026 Organ Procurement Organization (OPO) Guidance reinforces existing donor-process safeguards while signaling increased...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    CMS Proposes Overhaul Of Skin Substitute Reimbursement Policy Beginning January 2026 - Implications For Providers, Manufacturers, And Payers In Both Outpatient And Physician Office Settings

    On July 16, 2025, the U.S. Department of Health and Human Services' (HHS) Centers for Medicare & Medicaid Services (CMS) published its CY 2026 Medicare Physician Fee Schedule...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Benesch, Friedlander, Coplan & Aronoff LLP
    Benesch, Friedlander, Coplan & Aronoff LLP
  • Article

    CMS Publishes Calendar Year 2023 Hospital Outpatient Payment Final Rule And Addresses 340B Drug Payments, Organ Acquisition Costs, Pandemic-Related Payment Changes, Rural Hospitals

    On November 1, 2022, the Centers for Medicare & Medicaid Services ("CMS") published the final rule for the calendar year ("CY") 2023 outpatient prospective payment system ("OPPS")...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray
    Ropes & Gray
  • Article

    Court Rules That CMS Cannot Extrapolate Medicare Advantage Risk Adjustment Audit Results

    On September 25, a federal district court vacated the Medicare Advantage risk adjustment and data validation ("RADV") final rule that would have enabled the Centers...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Groom Law Group, Chartered
    Groom Law Group, Chartered
  • Article

    Preview Of Medicare Advantage And Part D Advance Notice And Call Letter: CMS Likely To Address Risk Adjustment, Provider Network, And Other Issues

    In the CY 2016 Draft Call Letter, CMS stated its expectation that Part D Plan Sponsors develop and implement a soft point-of-sale (POS) edit to prevent opioid overutilization.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    CMS Makes Things Nonexclusive: Immediate Changes To The Stark Law Will Impact Health Care Leases

    On November 20, 2020, CMS issued its Final Rule (the "Final Rule") modifying various Stark Law regulations, including those specifically geared toward real estate arrangements.
    United StatesReal Estate and Construction
    Hall, Render, Killian, Health & Lyman
    Hall, Render, Killian, Health & Lyman
  • Article

    Blog Series: CMS Proposed Rule On Policy And Technical Changes To The Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, And Medicaid Managed Care Programs For Years 2020 And 2021

    On October 26, 2018, the Centers for Medicare and Medicaid Services ("CMS") released for viewing a proposed rule that includes significant changes for Medicare Advantage organizations ("MAOs"),
    United StatesAccounting and Audit
    Sheppard
    Sheppard
  • Article

    CMS Proposes Transitional Coverage For Emerging Technologies

    The Centers for Medicare & Medicaid Services (CMS) recently issued a long-awaited Notice with Comment Period outlining a proposed Transitional Coverage for Emerging Technologies (TCET)...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    CMS Issues First Request For Public Comments On The Medicare Drug Price Negotiation Program "Small Biotech" Exception – Due March 27, 2023

    The Inflation Reduction Act's ("IRA") drug price negotiation provisions have captured the pharmaceutical and biotech industry's attention. In part, the IRA allows the Centers for Medicare & Medicaid
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Program Integrity Changes To The Medicare Provider Enrollment Process

    On March 1, 2016, the U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services published a proposed rule entitled "Medicare, Medicaid, and Children's Health Insurance Programs; Program Integrity Enhancements to the Provider Enrollment Process".
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    CMS Medicare Advantage RADV Final Rule: No Fee-For-Service Adjuster, May Extrapolate Audit Findings Beginning With PY 2018

    More than four years after it was proposed, on February 1, 2023 the Centers for Medicare & Medicaid Services ("CMS") published the long-awaited risk adjustment data validation ("RADV") Final Rule ("Final Rule")...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Groom Law Group, Chartered
    Groom Law Group, Chartered
  • Article

    CMS Proposed Rule Reflects Increased Sophistication In Administration Of MA/Part D Programs

    Addressing issues ranging from participation in Part D Plan pharmacy networks to compliance training for so-called first-tier, downstream and related entities, the Proposed Rule covers numerous topics with varying degrees of importance for Medicare Advantage Organizations, Part D Plan Sponsors, pharmacy benefit managers, pharmacies, and other health care and administrative service providers.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    CMS Proposes Exceptions, Revisions And Requests Comments To Ease Stark Law Compliance

    The Centers for Medicare & Medicaid Services (CMS) recently proposed regulatory changes to the Stark Law that may ease certain compliance challenges.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    CMS Issues Long-Awaiting Medicare Advantage RADV Final Rule

    On January 30, 2023, the Centers for Medicare & Medicaid Services released the long-delayed final rule on risk adjustment data validation audits of Medicare Advantage organizations
    United StatesFood, Drugs, Healthcare, Life Sciences
    Sheppard
    Sheppard
  • Article

    CMS Updates Waivers, Provides More Flexibility For Providers Responding To COVID-19

    As the COVID-19 emergency continues to heavily impact the U.S. and its health care system, CMS has issued additional flexibilities for providers and payors seeking to respond to the pandemic.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Sheppard
    Sheppard
  • Article

    CMS Proposes $9 Billion Refund To 340B Hospitals And Reductions In Future Payments To All Hospitals For Non-Drug Services

    On July 7, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to implement a remedy in response to last year's Supreme Court decision finding the Medicare Part B payment...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS Proposes Value-Based Purchasing Model, Other Updates To The 2016 Home Health Prospective Payment System

    The U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services published its proposed update to the home health prospective payment system for calendar year 2016 in the July 10, 2015 Federal Register.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery

Showing 561–580 of 15707 results

PreviousNext
Legal Intelligence Newsletters